Maria Teresa Hilado to Join Galderma’s Advisory Committee
7.12.2021 12:00:00 EET | Business Wire | Press release
Galderma, the world’s largest independent dermatology company, announced today that Maria Teresa “Tessa” Hilado will join its Advisory Committee, effective January 1, 2022.
Ms. Hilado currently serves on the board of directors at Campbell Soup Company, Zimmer Biomet Holdings, Inc. and Pharmaceutical Product Development, LLC.
“I look forward to working with Tessa Hilado as we
move forward with Galderma’s next growth phase.
Her appointment will greatly strengthen the Advisory Committee and shows our dedication to
increasing diversity at Galderma.”
THOMAS EBELING
CHAIRMAN OF THE ADVISORY COMMITTEE, GALDERMA
A financial management specialist with over 30 years’ experience, Ms. Hilado brings a proven track record across several global corporations and brands. Her background includes pharmaceuticals, consumer products and industrials.
She most recently served as Executive Vice President and Chief Financial Officer at global pharmaceutical company Allergan PLC, from 2014 until her retirement in 2018. Prior to this, Ms. Hilado was Senior Vice President, Finance and Treasurer of PepsiCo Inc.; Vice President and Treasurer for Schering-Plough Corp.; and held several leadership roles at General Motors Company.
She holds a Bachelor of Science in Management Engineering from Ateneo de Manila University in the Philippines and an MBA from the University of Virginia Darden School of Business.
“I am thrilled to welcome Tessa to Galderma’s
Advisory Committee. Her vast expertise will be
instrumental in implementing our integrated
dermatology strategy and in fulfilling our ambition of
becoming the leading dermatology company in the
world.”
FLEMMING ØRNSKOV, M.D., MPH
CHIEF EXECUTIVE OFFICER, GALDERMA
About Galderma
Galderma is the world’s largest independent dermatology company, present in approximately 100 countries. Since our inception in 1981, we have been driven by a complete dedication to dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Aesthetics, Consumer Care and Prescription Medicine. Focused on the needs of consumers and patients, we work in partnership with healthcare professionals to ensure superior outcomes. Because we understand that the skin we’re in shapes our life stories, we are advancing dermatology for every skin story. For more information: www.galderma.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211207005498/en/
Contact information
Media contact
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50
Sébastien Cros
Corporate Communications Director
sebastien.cros@galderma.com
+41 79 529 59 85
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ushio Completes Acquisition of OSRAM Entertainment and Industry Business5.3.2026 16:08:00 EET | Press release
Ushio Inc. today announced the successful completion of the acquisition of the OSRAM Entertainment and Industry (ENI) business. As of March 2, 2026, the business officially operates as part of the Ushio Group under the name Ushio INE GmbH (hereinafter: Ushio Industry & Entertainment). This strategic acquisition strengthens Ushio’s global position in specialty lighting and expands its capabilities across entertainment, cinema projection, stage lighting, industrial applications, and high-performance professional solutions. The newly integrated organization combines Ushio’s established technology portfolio and global manufacturing strength with the long-standing expertise, customer relationships, and application knowledge of the former OSRAM Entertainment and Industry team. Marko Haas, General Manager of Business Division of Ushio Industry & Entertainment, commented: “This marks an important milestone for our business and our customers worldwide. By bringing together the experience and tr
Adaptive announces strategic investment from HSBC and Citi to fuel capital markets technology innovation5.3.2026 15:01:00 EET | Press release
Adaptive, a leader in custom trading technology solutions, announces it has secured strategic investment from two prominent global financial institutions, Citi and HSBC. This funding is set to significantly accelerate Adaptive’s growth and product innovation roadmap. The strategic backing from HSBC and Citi underscores the collaboration between Adaptive and two of the world’s largest financial institutions on strategic initiatives to reshape capital markets technology. It will enable Adaptive to capitalize on significant technological disruption and meet the growing demand for client‑owned, differentiated and bespoke trading technology. Centered around Adaptive’s suite of Aeron®products, the funding allows the company to scale its delivery of high-performance, cloud-native solutions amidst evolving market dynamics and heightened competition. The investment comes at a pivotal moment as liquidity and trading infrastructure increasingly migrate to the cloud, and the adoption of open-sourc
CPAC Systems AB Chooses RideController, Inc. Accelerating Intelligent Boat Innovation5.3.2026 15:00:00 EET | Press release
CPAC Systems AB today announces a partnership between its premium marine integration platform Marivue and RideController, Inc. RideController becomes an Integrated Experience Partner within the Marivue ecosystem, advancing integration, automation, and user experience for next generation watersports and recreational boats. The partnership combines Marivue’s digital dashboard, integrated boat architecture, and Horizon cloud platform with RideController’s next generation power distribution and LED control systems. Together, the companies will deliver a fully integrated electrical and lighting experience for watersports and premium recreational vessels. Rather than treating switching and lighting as separate subsystems, the collaboration establishes a cohesive digital and electrical backbone. RideController’s distributed solid state power and advanced LED control technology will integrate into Marivue products, enabling unified control, diagnostics, and mode based automation. “RideControll
LabVantage Solutions Introduces LabVantage CORTEX, Advancing Its LIMS Platform for AI-Driven Laboratory Operations5.3.2026 14:30:00 EET | Press release
LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced the launch of LabVantage CORTEX, a next-generation artificial intelligence (AI), analytics, and automation platform. The launch represents a strategic evolution of the company’s laboratory informatics portfolio, integrating advanced AI and smarter automation into the core LabVantage LIMS experience to help laboratories operate with greater accuracy, efficiency, and confidence. LabVantage CORTEX is built to support the growing demand for intelligent, automated laboratory environments across industries, including pharma and biotech, food and beverage, oil and gas, forensics, and more. LabVantage CORTEX provides a customer-centric AI analytics and automation ecosystem that helps laboratories improve efficiency, reduce errors, and deepen data insights to accelerate R&D. This shift is timely, as a recent survey found that more than 75% of labs plan to implement AI and machine lear
Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 09:00:00 EET | Press release
Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a wholly owned subsidiary of Radiology Partners, the largest radiology practice in the U.S, with more than 4,000 radiologists in its network. Cognita CXR1 applies a proprietary
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom